In our previous study, the improved adenovirus was used for constructing an adenovirus-mediated Aurora A shRNA driven by stathmin promoter, the loss-of-function results of which showed it could suppress tumor growth and enhance paclitaxel chemotherapy sensitivity in human breast carcinoma cells, more importantly not detrimental to normal cells [17]. Here, STMN1 is linked to breast carcinoma.